Join us for Cleveland Clinic’s Global EP Summit 2026.
Cleveland Clinic’s 8th Annual Global EP Summit 2026 is a two-day symposium to discuss innovations in devices, techniques, recent clinical trials, and current guidelines in cardiac electrophysiology. Topics include updates on catheter ablation, stroke prevention in atrial fibrillation, ventricular arrhythmia ablation, new frontiers in pacing and lead management, and sudden cardiac death and CHD. This meeting will provide attendees with a thorough and practical course on the current state of the art in the field and provide an opportunity for both faculty and attendees to interact in a forum which will encourage an open discussion of arrhythmia management, perceived challenges, and future directions.
Returning this year is a fellow’s symposium on Saturday afternoon, September 19!
After completing this activity, participants will be able to:
- Evaluate and apply contemporary catheter ablation strategies for ventricular arrhythmias by incorporating pre-procedural MRI and CT for VT circuit identification, assessing the feasibility and outcomes of substrate-based VT ablation without VT induction, interpreting early clinical lessons from pulsed field ablation for ventricular arrhythmias, and selecting mapping and ablation approaches for challenging idiopathic ventricular arrhythmia sites and ventricular fibrillation triggers or substrate.
- Integrate and evaluate emerging evidence and new technologies for the prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation.
- Assess candidacy for ventricular tachycardia ablation in high-risk patients, appraise the current and emerging roles of cardiac radio-ablation and cardiac sympathetic denervation for refractory VT/VF, and apply multidisciplinary clinical reasoning to complex ventricular arrhythmia cases to guide individualized management decisions.
- Apply an individualized approach to atrial fibrillation management by integrating evolving AF classification concepts, atrial myopathy assessment, heart failure and sleep apnea comorbidity considerations, obesity management strategies, and continuous monitoring data to inform the timing and selection of AF ablation.
- Discuss strategies to improve treatment outcomes in patients with ventricular arrhythmias and structural heart disease, including new ablation techniques and technologies.
- Evaluate diverse causes of sudden cardiac death across congenital heart disease, younger patient populations, and inherited channelopathies, and apply a systematic diagnostic approach to postural orthostatic tachycardia syndrome to improve risk assessment, differential diagnosis, and management planning.
Who Should Attend?
The course is directed to physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and all healthcare providers with an interest in electrophysiology.